DBS

Happiest Minds announces the formation of Product and Digital Engineering Services (PDES) Business Unit

Retrieved on: 
Wednesday, October 18, 2023
Digital, DBS, Small Business Saturday, Generative, Volvo Business Units, GBS, Digital transformation, NSE, IMSS, PDES, Corporate services, Born Digital, PES, Instrumentation

Born Agile', Mindful IT Company, announced the formation of the Product and Digital Engineering Services (PDES) Business Unit by combining the Product Engineering Services (PES) and Digital Business Services (DBS) Business Units.

Key Points: 
  • Born Agile', Mindful IT Company, announced the formation of the Product and Digital Engineering Services (PDES) Business Unit by combining the Product Engineering Services (PES) and Digital Business Services (DBS) Business Units.
  • Joseph Anantharaju, who has been responsible for the consistent success of the Product Engineering Services BU from its inception, will take responsibility for this merged Business Unit and lead it to continued success.
  • Joseph Anantharaju, Executive Vice Chairman, Happiest Minds, said, "I am gratified to have been a part of Happiest Minds' successful journey since its inception, leading our Product Engineering Services BU to consistent and market-leading results.
  • I am excited to lead the merged Product and Digital Engineering Services (PDES) Business Unit and contribute to our $1bn journey by 2031. "

Happiest Minds announces the formation of Product and Digital Engineering Services (PDES) Business Unit

Retrieved on: 
Wednesday, October 18, 2023
Digital, DBS, Small Business Saturday, Generative, Volvo Business Units, GBS, Digital transformation, NSE, IMSS, PDES, Corporate services, Born Digital, PES, Instrumentation

Born Agile', Mindful IT Company, announced the formation of the Product and Digital Engineering Services (PDES) Business Unit by combining the Product Engineering Services (PES) and Digital Business Services (DBS) Business Units.

Key Points: 
  • Born Agile', Mindful IT Company, announced the formation of the Product and Digital Engineering Services (PDES) Business Unit by combining the Product Engineering Services (PES) and Digital Business Services (DBS) Business Units.
  • Joseph Anantharaju, who has been responsible for the consistent success of the Product Engineering Services BU from its inception, will take responsibility for this merged Business Unit and lead it to continued success.
  • Joseph Anantharaju, Executive Vice Chairman, Happiest Minds, said, "I am gratified to have been a part of Happiest Minds' successful journey since its inception, leading our Product Engineering Services BU to consistent and market-leading results.
  • I am excited to lead the merged Product and Digital Engineering Services (PDES) Business Unit and contribute to our $1bn journey by 2031. "

Revvity and Element Biosciences Announce Collaboration to Improve Next Generation Sequencing Research Workflow

Retrieved on: 
Monday, October 16, 2023
Health, Medical Devices, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Element, DBS, Somatosensory system, Genome, NGS, Quality control, Data management, Laboratory, Workflow, Collection, SVP, Publication, Data analysis, Fine chemical

Revvity, Inc. and Element Biosciences, Inc. , a developer of the AVITI™ System , an innovative and emerging genomic sequencing platform, today announced a collaboration to introduce workflow solutions that save time and effort required for genomic analysis of samples.

Key Points: 
  • Revvity, Inc. and Element Biosciences, Inc. , a developer of the AVITI™ System , an innovative and emerging genomic sequencing platform, today announced a collaboration to introduce workflow solutions that save time and effort required for genomic analysis of samples.
  • Genomic data generated by next generation sequencing (NGS) plays an increasingly important role in scientific innovation and research.
  • Revvity offers carefully curated research use components, spanning the NGS continuum around the sequencing platform.
  • Revvity and Element Biosciences plan to make the combined solution available to an expanded customer base interested in the full workflow or specific modules.

AECOM joint venture to provide program management services for the Chicago Department of Water Management’s capital improvement program

Retrieved on: 
Thursday, October 5, 2023
Professional Services, Logistics, Supply Chain Management, Mining, Minerals, Sustainability, Green Technology, Natural Resources, Engineering, Contracts, Public Transport, Utilities, Oil, Gas, Manufacturing, Coal, Alternative Energy, Energy, Trucking, Rail, Maritime, Air, Transport, Nuclear, Defense, Environment, Building Systems, Urban Planning, Landscape, Consulting, Architecture, Construction & Property, Partnership, Health, Knowledge, NYSE, Plant, DBS, Drinking water, Science and technology in Asia, Tree, DWM, ACM, Safety, City, Rehabilitation, Chicago Department of Transportation, Water purification, Renewable energy, AECOM

AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, announced today that its AECOM-DBS joint venture with minority-owned business enterprise partner DB Sterlin (DBS) has been awarded a 3-year contract to provide program management services to the Chicago Department of Water Management (DWM).

Key Points: 
  • AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, announced today that its AECOM-DBS joint venture with minority-owned business enterprise partner DB Sterlin (DBS) has been awarded a 3-year contract to provide program management services to the Chicago Department of Water Management (DWM).
  • In this role, AECOM-DBS will manage the capital improvement program for DWM’s facilities, which deliver nearly 750 million gallons of drinking water to residents daily.
  • Work will focus on numerous DWM assets, including improvements to its 4,300-mile water distribution system, 12 pumping stations, and two of the world’s largest water purification plants.
  • “We’re proud to build on our longstanding partnership collaborating with DBS on dozens of projects in Chicago to lead DWM’s capital improvement program,” said Beverley Stinson, chief executive of AECOM’s global Water business.

The Hackett Group Announces 2023 Digital Award Winners

Retrieved on: 
Thursday, October 5, 2023
Technology, Finance, Consulting, Professional Services, Software, Networks, Internet, Data Management, Other Professional Services, Knowledge, Algorithm, Simon Hackett, DBS, NLU, Customer experience, Intelligence, Abstract, Automation, MTN, AI, SAP, Digital contact tracing, Digital, Operational excellence, Artificial intelligence, Runbook, Remix, Platform as a service, System, Signavio, Synthetic media, Information technology, Mining, Talent, DBS Bank, ROI, African, Infrastructure as a service, Service provider, Association of Media in Digital Awards, Online shopping, Sales, 3D printing, Video game, Mobile phone, Sanofi

The Hackett Group , Inc. (NASDAQ: HCKT) today announced the winners of its 10th Annual Digital Awards, which spotlight companies that are on the cutting edge of creating competitive advantage and delivering measurable benefits at scale using digital transformation solutions.

Key Points: 
  • The Hackett Group , Inc. (NASDAQ: HCKT) today announced the winners of its 10th Annual Digital Awards, which spotlight companies that are on the cutting edge of creating competitive advantage and delivering measurable benefits at scale using digital transformation solutions.
  • The 2023 Digital Award winners and their win categories are: Bosch Service Solutions GmbH (Contact-to-Resolution); DBS Bank Ltd (Technology Function Operations); F. Hoffmann-La Roche Ltd. (Plan-to-Source-to-Make-to-Deliver); IBM International Services Centre Slovakia (Order-to-Cash); MTN Group Global Sourcing and Supply Chain (Source-to-Purchase); and Sanofi (Talent Management).
  • According to Vin Kumar, managing partner, AI and Digital Operations practice leader at The Hackett Group®, “This year’s winners demonstrate the real progress that’s being made as automation becomes more intelligent.
  • Our 2023 Digital Award winners are building automation fabrics that generate real insights about customers, suppliers, users, employees and more, then use those insights to make better decisions.

Veralto Begins Trading as Public Company

Retrieved on: 
Monday, October 2, 2023
Linx, Human, Food, Drinking water, VES, Danaher, OTT, Innovation, Medicine, Water cycle, Recycling, Danaher Corporation, Water quality, DBS, Pantone, Vital, Water, XOS, Quality control, Growth, NYSE, Safety, Bottled water, Medical device, Hach

WALTHAM, Mass., Oct. 2, 2023 /PRNewswire/ -- Today marked the first day of regular way trading for Veralto (NYSE: VLTO) as it begins its new journey as a publicly traded company.

Key Points: 
  • Veralto separated from its former parent, Danaher Corporation, on September 30, 2023.
  • "At Veralto, we are driven by our purpose: Safeguarding the World's Most Vital Resources," said Jennifer L. Honeycutt, President and Chief Executive Officer of Veralto.
  • The success of the Veralto operating companies is bolstered by the organization's use of the Veralto Enterprise System (VES), a derivative of the Danaher Business System (DBS).
  • Jennifer L. Honeycutt and the Veralto Executive Team will commemorate the new public listing of the company by ringing the opening bell at the New York Stock Exchange on Monday, October 9, 2023.

INBRAIN Neuroelectronics Announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform

Retrieved on: 
Tuesday, September 19, 2023
Neurology, FDA, Medical Devices, Health, Health Technology, BCI, Multimedia, Steel, Carbon, Biomarker, Science, DBS, BDD, Neuropsychiatric Disease and Treatment, Stanford University School of Medicine, Patient, Subthalamic nucleus, STN, Neuro, Breakthrough, Pharmaceutical industry, Medical imaging, Medical device

, a health-tech company dedicated to developing the world’s first intelligent graphene-neural platform, today announced that its Intelligent Network Modulation System has been granted Breakthrough Device Designation (BDD) from the U.S. Food & Drug Administration (FDA) as an adjunctive therapy for treating Parkinson’s disease.

Key Points: 
  • , a health-tech company dedicated to developing the world’s first intelligent graphene-neural platform, today announced that its Intelligent Network Modulation System has been granted Breakthrough Device Designation (BDD) from the U.S. Food & Drug Administration (FDA) as an adjunctive therapy for treating Parkinson’s disease.
  • The thinnest material known, yet stronger than steel, graphene’s unique combination of electrical and mechanical properties makes it ideal for neurotechnology innovation.
  • “Breakthrough device designation from the FDA signifies the potential of the INBRAIN neural platform to further improve the lives of patients with Parkinson’s disease,” said INBRAIN Neuroelectronics Clinical Affairs Head Dan Gnansia.
  • “INBRAIN’s new generation of ultrathin graphene-based high resolution interfaces and associated network platform may vastly improve the precision, efficiency and efficacy of DBS and closed-loop or adaptive modulation.

Exploring Parkinson's Disease Statistics: Market Insight, Epidemiology ,Forecast Price and Market Access ,Commercial Strategy Analysis, Drug Development & Healthcare Consulting Services by Disease landscape Insights

Retrieved on: 
Thursday, September 14, 2023
Non-invasive ventilation, Health care, DSM-IV codes, Diverticulitis, Cerebrospinal fluid, Protein, Patient, Risk, Disease, Tremor, Genetics, Spinal cord, Gait abnormality, Genetic testing, Brain, Dopamine, Research, Approximation error, Magnetic resonance, Biomarker, Parkinson's disease, DLI, Diagnosis, Alzheimer's disease, FDA, Magnetic resonance imaging, Horizon, Safety, Exercise, Functional magnetic resonance imaging, DBS, Algorithm, Roger Hawkins (drummer), Research and development, Central nervous system, Clinical trial, Quality of life, Deep brain stimulation, Movement, MRI, L-DOPA, Scan (company), AI, Artificial intelligence, Pharmaceutical industry, Medical imaging, Medical device, Forestry, Dietary supplement

Advancements in Parkinson's Disease Diagnosis: Facilitating Patient Care

Key Points: 
  • Advancements in Parkinson's Disease Diagnosis: Facilitating Patient Care
    Parkinson's Disease can be challenging to diagnose, often leading to delayed treatment initiation.
  • However, recent advancements in diagnostic tools have empowered healthcare professionals to identify the disease more accurately and at earlier stages.
  • DiseaseLandscape Insights is at the forefront of drug insights and discovery, product launches, and clinical trial feasibility analysis in the fight against Parkinson's Disease.
  • The Parkinson's Disease Overview by healthcare consulting services provider DLI shows that it is competitive, with pharmaceutical companies vying to develop better treatments.

GIP Launched ASEAN Chapter, Vision 2026 and New WG at its 5th Plenary Meeting

Retrieved on: 
Thursday, September 7, 2023
Chapter, BRI, ASEAN, Senior, Lord, Standard Chartered, EM, Disclosure, ISSB, World Bank, Standard, Vision, DBS, Biodiversity, HM, International Liaison Department of the Chinese Communist Party, City, Climate change, MD, Nature, FIS, PBOC, G20, GIP, BOC, Belt, Secretariat, JIN, WG, Renewable energy

BEIJING, Sept. 7, 2023 /PRNewswire/ -- The 5th Plenary Meeting of the Green Investment Principles (GIP) for the Belt and Road was successfully convened in Beijing.

Key Points: 
  • BEIJING, Sept. 7, 2023 /PRNewswire/ -- The 5th Plenary Meeting of the Green Investment Principles (GIP) for the Belt and Road was successfully convened in Beijing.
  • To reflect global trends in sustainable finance, GIP renews its medium-term strategy and announced Vision 2026/2030, which introduces the "Transition" pillar.
  • A GIP casebook was launched to demonstrate good practices in green investments along the Belt and Road and implementation of GIP principles.
  • In recognition of exceptional implementation of GIP principles and product innovation by its members, the Secretariat announced winners of the 2023 GIP Awards.

CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients

Retrieved on: 
Friday, September 1, 2023
Gaucher's disease, GBA1, Diagnosis, Prognosis, GD, DBS, Patient, Collection, Physician, CNTG, Enzyme replacement therapy, Medical imaging, Gaucher

“Over the past decade, we have leveraged all our multiomic technological know-how to establish and confirm lyso-Gb1 as the best biomarker for Gaucher disease,” said Professor Peter Bauer, CENTOGENE’s Chief Medical and Genomic Officer.

Key Points: 
  • “Over the past decade, we have leveraged all our multiomic technological know-how to establish and confirm lyso-Gb1 as the best biomarker for Gaucher disease,” said Professor Peter Bauer, CENTOGENE’s Chief Medical and Genomic Officer.
  • “This landmark study further advances our understanding of Gaucher disease patients – demonstrating a significant correlation between lyso-Gb1 levels and disease severity.
  • The results of the study revealed a highly significant correlation between lyso-Gb1 and disease severity in all Gaucher patients, including those with novel rare GBA1 variants.
  • “The progressive increase in lyso-Gb1 levels in untreated Gaucher patients suggests that these patients could benefit from treatment, such as enzyme replacement therapy.